DE60121426D1 - Pharmazeutische zusammensetzung zur behandlung und vorbeugung von leberzirrhose und leberfibrose - Google Patents

Pharmazeutische zusammensetzung zur behandlung und vorbeugung von leberzirrhose und leberfibrose

Info

Publication number
DE60121426D1
DE60121426D1 DE60121426T DE60121426T DE60121426D1 DE 60121426 D1 DE60121426 D1 DE 60121426D1 DE 60121426 T DE60121426 T DE 60121426T DE 60121426 T DE60121426 T DE 60121426T DE 60121426 D1 DE60121426 D1 DE 60121426D1
Authority
DE
Germany
Prior art keywords
liver
prevention
treatment
pharmaceutical composition
liver fibrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121426T
Other languages
English (en)
Other versions
DE60121426T2 (de
Inventor
Geon Kim
Wook Kang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60121426D1 publication Critical patent/DE60121426D1/de
Publication of DE60121426T2 publication Critical patent/DE60121426T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE60121426T 2000-03-02 2001-03-02 Pharmazeutische zusammensetzung zur behandlung und prävention der leberfibrose und-zirrhose Expired - Lifetime DE60121426T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR2000010540 2000-03-02
KR20000010540 2000-03-02
PCT/KR2001/000320 WO2001064215A1 (en) 2000-03-02 2001-03-02 Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis

Publications (2)

Publication Number Publication Date
DE60121426D1 true DE60121426D1 (de) 2006-08-24
DE60121426T2 DE60121426T2 (de) 2007-02-22

Family

ID=36776473

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121426T Expired - Lifetime DE60121426T2 (de) 2000-03-02 2001-03-02 Pharmazeutische zusammensetzung zur behandlung und prävention der leberfibrose und-zirrhose

Country Status (10)

Country Link
EP (1) EP1263435B1 (de)
JP (1) JP4226246B2 (de)
CN (1) CN1218698C (de)
AT (1) ATE332693T1 (de)
AU (1) AU2001237768A1 (de)
BR (1) BR0108732A (de)
DE (1) DE60121426T2 (de)
ES (1) ES2267722T3 (de)
RU (1) RU2250768C2 (de)
WO (1) WO2001064215A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030067935A (ko) * 2002-02-09 2003-08-19 김상건 올티프라즈를 포함하는 간경화(간경변증) 치료를 위한 간 조직 재생용 제약 조성물
KR100629771B1 (ko) * 2004-01-27 2006-09-28 씨제이 주식회사 결정성이 감소되거나 무정형화된 올티프라즈의 제조방법
KR100604261B1 (ko) 2004-10-11 2006-07-28 재단법인서울대학교산학협력재단 신규4,5,6,7-테트라히드로-[1,2]디티올로[4,3-ｃ]피리딘-3-티온계 화합물
WO2007131973A2 (en) * 2006-05-11 2007-11-22 Prendergast Patrick T Compositions and methods for modulating the immune system

Also Published As

Publication number Publication date
WO2001064215A1 (en) 2001-09-07
JP4226246B2 (ja) 2009-02-18
JP2004538239A (ja) 2004-12-24
CN1407891A (zh) 2003-04-02
CN1218698C (zh) 2005-09-14
EP1263435A4 (de) 2004-08-11
DE60121426T2 (de) 2007-02-22
EP1263435A1 (de) 2002-12-11
ES2267722T3 (es) 2007-03-16
ATE332693T1 (de) 2006-08-15
AU2001237768A1 (en) 2001-09-12
RU2002126216A (ru) 2004-03-20
EP1263435B1 (de) 2006-07-12
RU2250768C2 (ru) 2005-04-27
BR0108732A (pt) 2002-12-17

Similar Documents

Publication Publication Date Title
ATE234634T1 (de) Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff
ATE269846T1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
HUP0303037A3 (en) Compounds to treat alzheimer's disease and pharmaceutical compositions containing them
MY129406A (en) Taste masked liquid pharmaceutical compositions
RS20110578A2 (en) MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULPHONAMIDES AS HCV REPLICATION INHIBITORS
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
HUP0302508A3 (en) Pyridazinones and triazinones and their use as active ingredients of pharmaceutical compositions
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
DE69919533D1 (de) Proteinhaltige arzneimittel
BG106155A (en) Novel derivatives and analogues of galanthamin
WO2005065639A3 (en) Novel pharmaceutical compositions
DE50115451D1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
CA2473202A1 (en) Pharmaceutical composition for regeneration of cirrhotic liver
ATE296635T1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
MY141506A (en) Virus therapeutic drug
ATE332693T1 (de) Pharmazeutische zusammensetzung zur behandlung und vorbeugung von leberzirrhose und leberfibrose
ATE404192T1 (de) Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration
RS60604A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
DE60107900D1 (de) Pharmazeutische Zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem
DK1492539T3 (da) Statin-terapi til forögelse af kognitiv funktion
DE602004025103D1 (de) Heilkräuterzusammensetzung zur Behandlung von AIDS
ATE413171T1 (de) Pharmazeutische zusammensetzungen mit ascorbinsäure zur behandlung von pilz- superinfektionen und pilz-rezidiven

Legal Events

Date Code Title Description
8364 No opposition during term of opposition